{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:36:49Z","timestamp":1793893009252,"version":"4.8.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T00:00:00Z","timestamp":1489622400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 2013 14696"],"award-info":[{"award-number":["IG 2013 14696"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005743","name":"Universit\u00e0 Cattolica del Sacro Cuore","doi-asserted-by":"publisher","award":["D.1\/2013-70201056 and D.1 2014-70201266"],"award-info":[{"award-number":["D.1\/2013-70201056 and D.1 2014-70201266"]}],"id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s12020-017-1273-x","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T03:56:31Z","timestamp":1489636591000},"page":"368-379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":141,"title":["Increased incidence trend of low-grade and high-grade neuroendocrine neoplasms"],"prefix":"10.1007","volume":"58","author":[{"given":"Emanuele","family":"Leoncini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Boffetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail","family":"Shafir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katina","family":"Aleksovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Boccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2996-4404","authenticated-orcid":false,"given":"Guido","family":"Rindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,16]]},"reference":[{"key":"1273_CR1","first-page":"1","volume-title":"Diagnostic and Therapeutic Nuclear Medicine for Neuroendocrine Tumors. Contemporary Endocrinology","author":"F Inzani","year":"2017","unstructured":"F. Inzani, G. Rindi. Classification of Neuroendocrine Neoplasms. in Diagnostic and Therapeutic Nuclear Medicine for Neuroendocrine Tumors. Contemporary Endocrinology. ed. by K. Pacak, D. Ta\u00efeb (Springer, Cham, 2017), pp. 1\u201314"},{"key":"1273_CR2","first-page":"10","volume-title":"World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of the Digestive System","author":"G Rindi","year":"2010","unstructured":"G. Rindi, R. Arnold, C. Capella, D.S. Klimstra, G. Kl\u00f6ppel, P. Komminoth, E. Solcia. Nomenclature and classification of digestive neuroendocrine tumours. in World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of the Digestive System. ed.by F. Bosman, F. Carneiro (IARC, Lyon, 2010) pp. 10\u201312"},{"issue":"1","key":"1273_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000445165","volume":"104","author":"M Milione","year":"2017","unstructured":"M. Milione, P. Maisonneuve, F. Spada, A. Pellegrinelli, P. Spaggiari, L. Albarello, E. Pisa, M. Barberis, A. Vanoli, R. Buzzoni, S. Pusceddu, L. Concas, F. Sessa, E. Solcia, C. Capella, N. Fazio, S. La Rosa, The clinicopathologic heterogeneity of grade 3 gastroenteropancreatic neuroendocrine neoplasms: morphological differentiation and proliferation identify different prognostic categories. Neuroendocrinology 104(1), 85\u201393 (2017). doi: 10.1159\/000445165","journal-title":"Neuroendocrinology"},{"key":"1273_CR4","doi-asserted-by":"crossref","unstructured":"M.B. Amin, S.B. Edge, F.L. Greene, D.R. Byrd, D.B. Brookland, M.K. Washington, J.E. Gershenwald, C.C. Compton, K.R. Hess, D.C. Sullivan, J.M. Jessup, J.D. Brierley, L.E. Gaspar, R.L. Schilsky, C.M. Balch, D.P. Winchester, E.A. Asare, M. Madera, D.M. Gress, L.R. Meyer (eds.), AJCC Cancer Staging. Manual, 8th ed. (Springer, New York, Philadelphia, 2017)","DOI":"10.1007\/978-3-319-40618-3"},{"key":"1273_CR5","unstructured":"E.A. Woltering, E.K. Bergsland, D.T. Beyer, T.M. O\u2019Dorisio, G. Rindi, D.S. Klimstra, L.H. Tang, D. Reidy-Lagunes, J.R. Strosberg, E.M. Wolin, A.I. Vinik, E.K. Nakakura, E.A. Asare, D.L. Bushnell, R.L. Schilsky, Y.-Z. Wang, M.K. Kim, E.H. Liu, R.T. Jensen, R.K.S. Wong, J.K. Ramage, K. Mallin, R.F. Pommier: Neuroendocrine tumors of the jejunum and ileum. In: M.B. Amin, S.B. Edge, F.L. Greene, D.R. Byrd, D.B. Brookland, M.K. Washington, J.E. Gershenwald, C.C. Compton, K.R. Hess, D.C. Sullivan, J.M. Jessup, J.D. Brierley, L.E. Gaspar, R.L. Schilsky, C.M. Balch, D.P. Winchester, E.A. Asare, M. Madera, D.M. Gress, L.R. Meyer (eds.) AJCC Cancer Staging Manual. (Springer, New York, Philadelphia, 2017), pp. 375\u2013387"},{"issue":"7","key":"1273_CR6","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1054\/bjoc.2000.1394","volume":"83","author":"F Levi","year":"2000","unstructured":"F. Levi, V.C. Te, L. Randimbison, G. Rindi, C. La Vecchia, Epidemiology of carcinoid neoplasms in Vaud, Switzerland, 1974-97. Br. J. Cancer 83(7), 952\u2013955 (2000). doi: 10.1054\/bjoc.2000.1394","journal-title":"Br. J. Cancer"},{"issue":"2","key":"1273_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0169-5002(03)90481-8","volume":"37","author":"H Skuladottir","year":"2002","unstructured":"H. Skuladottir, F.R. Hirsch, H.H. Hansen, J.H. Olsen, Pulmonary neuroendocrine tumors: incidence and prognosis of histological subtypes. A population-based study in Denmark. Lung Cancer 37(2), 127\u2013135 (2002). doi: 10.1016\/S0169-5002(03)90481-8","journal-title":"Lung Cancer"},{"key":"1273_CR8","doi-asserted-by":"publisher","unstructured":"C. Lepage, A.M. Bouvier, S. Manfredi, V. Dancourt, J. Faivre, Incidence and management of primary malignant small bowel cancers: a well-defined French population study. The American journal of gastroenterology 101(12), 2826\u20132832 (2006). doi: 10.1111\/j.1572-0241.2006.00854.x","DOI":"10.1111\/j.1572-0241.2006.00854.x"},{"issue":"10","key":"1273_CR9","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1002\/cncr.23883","volume":"113","author":"O Hauso","year":"2008","unstructured":"O. Hauso, B.I. Gustafsson, M. Kidd, H.L. Waldum, I. Drozdov, A.K. Chan, I.M. Modlin, Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer 113(10), 2655\u20132664 (2008). doi: 10.1002\/cncr.23883","journal-title":"Cancer"},{"issue":"12","key":"1273_CR10","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1038\/ajg.2010.341","volume":"105","author":"L Ellis","year":"2010","unstructured":"L. Ellis, M.J. Shale, M.P. Coleman, Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971. Am. J. Gastroenterol. 105(12), 2563\u20132569 (2010). doi: 10.1038\/ajg.2010.341","journal-title":"Am. J. Gastroenterol."},{"issue":"7","key":"1273_CR11","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1007\/s00268-010-0519-z","volume":"34","author":"K Landerholm","year":"2010","unstructured":"K. Landerholm, S. Falkmer, J. Jarhult, Epidemiology of small bowel carcinoids in a defined population. World J. Surg. 34(7), 1500\u20131505 (2010). doi: 10.1007\/s00268-010-0519-z","journal-title":"World J. Surg."},{"issue":"3","key":"1273_CR12","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s12253-011-9382-y","volume":"17","author":"A Caldarella","year":"2011","unstructured":"A. Caldarella, E. Crocetti, E. Paci, Distribution, incidence, and prognosis in neuroendocrine tumors: a population based study from a cancer registry. Pathol. Oncol. Res. 17(3), 759\u2013763 (2011). doi: 10.1007\/s12253-011-9382-y","journal-title":"Pathol. Oncol. Res."},{"issue":"4","key":"1273_CR13","doi-asserted-by":"publisher","first-page":"e62487","DOI":"10.1371\/journal.pone.0062487","volume":"8","author":"HJ Tsai","year":"2013","unstructured":"H.J. Tsai, C.C. Wu, C.R. Tsai, S.F. Lin, L.T. Chen, J.S. Chang, The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study. PLoS One 8(4), e62487 (2013). doi: 10.1371\/journal.pone.0062487","journal-title":"PLoS One"},{"key":"1273_CR14","doi-asserted-by":"publisher","unstructured":"C.M. Korse, B.G. Taal, M.L. van Velthuysen, O. Visser, Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: experience of two decades of cancer registry. European journal of cancer 49(8), 1975\u20131983 (2013). doi: 10.1016\/j.ejca.2012.12.022","DOI":"10.1016\/j.ejca.2012.12.022"},{"issue":"47","key":"1273_CR15","doi-asserted-by":"publisher","first-page":"9012","DOI":"10.3748\/wjg.v19.i47.9012","volume":"19","author":"H Scherubl","year":"2013","unstructured":"H. Scherubl, B. Streller, R. Stabenow, H. Herbst, M. Hopfner, C. Schwertner, J. Steinberg, J. Eick, W. Ring, K. Tiwari, S.M. Zappe, Clinically detected gastroenteropancreatic neuroendocrine tumors are on the rise: epidemiological changes in Germany. World J. Gastroenterol. 19(47), 9012\u20139019 (2013). doi: 10.3748\/wjg.v19.i47.9012","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"1273_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/cncr.29099","volume":"121","author":"J Hallet","year":"2015","unstructured":"J. Hallet, C.H. Law, M. Cukier, R. Saskin, N. Liu, S. Singh, Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer 121(4), 589\u2013597 (2015). doi: 10.1002\/cncr.29099","journal-title":"Cancer"},{"issue":"18","key":"1273_CR17","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"J.C. Yao, M. Hassan, A. Phan, C. Dagohoy, C. Leary, J.E. Mares, E.K. Abdalla, J.B. Fleming, J.N. Vauthey, A. Rashid, D.B. Evans, One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J. Clin. Oncol. 26(18), 3063\u20133072 (2008). doi: 10.1200\/JCO.2007.15.4377","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"1273_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/bjs.10034","volume":"103","author":"OM Sandvik","year":"2016","unstructured":"O.M. Sandvik, K. Soreide, E. Gudlaugsson, J.T. Kvaloy, J.A. Soreide, Epidemiology and classification of gastroenteropancreatic neuroendocrine neoplasms using current coding criteria. Br. J. Surg. 103(3), 226\u2013232 (2016). doi: 10.1002\/bjs.10034","journal-title":"Br. J. Surg."},{"issue":"1","key":"1273_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000442207","volume":"104","author":"R Boyar Cetinkaya","year":"2017","unstructured":"R. Boyar Cetinkaya, B. Aagnes, E. Thiis-Evensen, S. Tretli, D.S. Bergestuen, S. Hansen, Trends in incidence of neuroendocrine neoplasms in Norway: a report of 16,075 cases from 1993 through 2010. Neuroendocrinology 104(1), 1\u201310 (2017). doi: 10.1159\/000442207","journal-title":"Neuroendocrinology"},{"key":"1273_CR20","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, P. Group, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Br. Med. J. 339, b2535 (2009). doi: 10.1136\/bmj.b2535","journal-title":"Br. Med. J."},{"issue":"10","key":"1273_CR21","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1093\/annonc\/mdn351","volume":"19","author":"TR Halfdanarson","year":"2008","unstructured":"T.R. Halfdanarson, K.G. Rabe, J. Rubin, G.M. Petersen, Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann. Oncol. 19(10), 1727\u20131733 (2008). doi: 10.1093\/annonc\/mdn351","journal-title":"Ann. Oncol."},{"issue":"3","key":"1273_CR22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"H.J. Kim, M.P. Fay, E.J. Feuer, D.N. Midthune, Permutation tests for joinpoint regression with applications to cancer rates. Stat. Med. 19(3), 335\u2013351 (2000). doi:10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","journal-title":"Stat. Med."},{"issue":"5","key":"1273_CR23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1530\/ERC-13-0027","volume":"20","author":"FL Velayoudom-Cephise","year":"2013","unstructured":"F.L. Velayoudom-Cephise, P. Duvillard, L. Foucan, J. Hadoux, C.N. Chougnet, S. Leboulleux, D. Malka, J. Guigay, D. Goere, T. Debaere, C. Caramella, M. Schlumberger, D. Planchard, D. Elias, M. Ducreux, J.Y. Scoazec, E. Baudin, Are G3 ENETS neuroendocrine neoplasms heterogeneous? Endocr. Relat. Cancer 20(5), 649\u2013657 (2013). doi: 10.1530\/ERC-13-0027","journal-title":"Endocr. Relat. Cancer"},{"key":"1273_CR24","doi-asserted-by":"publisher","unstructured":"H. Sorbye, S. Welin, S.W. Langer, L.W. Vestermark, N. Holt, P. Osterlund, S. Dueland, E. Hofsli, M.G. Guren, K. Ohrling, E. Birkemeyer, E. Thiis-Evensen, M. Biagini, H. Gronbaek, L.M. Soveri, I.H. Olsen, B. Federspiel, J. Assmus, E.T. Janson, U. Knigge: Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study. Ann. Oncol. (2012). doi: 10.1093\/annonc\/mds276","DOI":"10.1093\/annonc\/mds276"},{"issue":"4","key":"1273_CR25","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1530\/ERC-15-0119","volume":"22","author":"M Heetfeld","year":"2015","unstructured":"M. Heetfeld, C.N. Chougnet, I.H. Olsen, A. Rinke, I. Borbath, G. Crespo, J. Barriuso, M. Pavel, D. O\u2019Toole, T. Walter; other Knowledge Network, m. Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms. Endocr. Relat. Cancer 22(4), 657\u2013664 (2015). doi: 10.1530\/ERC-15-0119","journal-title":"Endocr. Relat. Cancer"},{"issue":"5","key":"1273_CR26","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/PAS.0000000000000408","volume":"39","author":"O Basturk","year":"2015","unstructured":"O. Basturk, Z. Yang, L.H. Tang, R.H. Hruban, V. Adsay, C.M. McCall, A.M. Krasinskas, K.T. Jang, W.L. Frankel, S. Balci, C. Sigel, D.S. Klimstra, The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms. Am. J. Surg. Pathol. 39(5), 683\u2013690 (2015). doi: 10.1097\/PAS.0000000000000408","journal-title":"Am. J. Surg. Pathol."},{"key":"1273_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ctrv.2016.08.006","volume":"50","author":"N Fazio","year":"2016","unstructured":"N. Fazio, M. Milione, Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications. Cancer Treat. Rev. 50, 61\u201367 (2016). doi: 10.1016\/j.ctrv.2016.08.006","journal-title":"Cancer Treat. Rev."},{"issue":"10","key":"1273_CR28","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1634\/theoncologist.2015-0476","volume":"21","author":"R Coriat","year":"2016","unstructured":"R. Coriat, T. Walter, B. Terris, A. Couvelard, P. Ruszniewski, Gastroenteropancreatic well-differentiated grade 3 neuroendocrine tumors: review and position statement. Oncol. 21(10), 1191\u20131199 (2016). doi: 10.1634\/theoncologist.2015-0476","journal-title":"Oncol."},{"issue":"7","key":"1273_CR29","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/apt.12012","volume":"36","author":"CS Jianu","year":"2012","unstructured":"C.S. Jianu, R. Fossmark, T. Viset, G. Qvigstad, O. Sordal, R. Marvik, H.L. Waldum, Gastric carcinoids after long-term use of a proton pump inhibitor. Aliment. Pharmacol. Ther. 36(7), 644\u2013649 (2012). doi: 10.1111\/apt.12012","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"1273_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/annonc\/mdv505","volume":"27","author":"E Leoncini","year":"2016","unstructured":"E. Leoncini, G. Carioli, C. La Vecchia, S. Boccia, G. Rindi, Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis. Ann. Oncol. 27(1), 68\u201381 (2016). doi: 10.1093\/annonc\/mdv505","journal-title":"Ann. Oncol."},{"key":"1273_CR31","doi-asserted-by":"crossref","unstructured":"Prevention, C.f.D.C.a.: Current Cigarette Smoking Among Adults\u2013United States, in Morbidity and Mortality Weekly Report, 2005\u20132014, Vol. 64. (Prevention C.f.D.C.a. Washington, DC, 2015), pp. 1233\u20131240","DOI":"10.15585\/mmwr.mm6444a2"},{"issue":"4","key":"1273_CR32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ejcts.2010.08.036","volume":"39","author":"A Naalsund","year":"2011","unstructured":"A. Naalsund, H. Rostad, E.H. Strom, M.B. Lund, T.E. Strand, Carcinoid lung tumors--incidence, treatment and outcomes: a population-based study. Eur. J. Cardiothorac. Surg. 39(4), 565\u2013569 (2011). doi: 10.1016\/j.ejcts.2010.08.036","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"10","key":"1273_CR33","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/jnci\/djk179","volume":"99","author":"M Hashibe","year":"2007","unstructured":"M. Hashibe, P. Brennan, S. Benhamou, X. Castellsague, C. Chen, M.P. Curado, L. Dal Maso, A.W. Daudt, E. Fabianova, L. Fernandez, V. Wunsch-Filho, S. Franceschi, R.B. Hayes, R. Herrero, S. Koifman, C. La Vecchia, P. Lazarus, F. Levi, D. Mates, E. Matos, A. Menezes, J. Muscat, J. Eluf-Neto, A.F. Olshan, P. Rudnai, S.M. Schwartz, E. Smith, E.M. Sturgis, N. Szeszenia-Dabrowska, R. Talamini, Q. Wei, D.M. Winn, D. Zaridze, W. Zatonski, Z.F. Zhang, J. Berthiller, P. Boffetta, Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J. Natl. Cancer Inst. 99(10), 777\u2013789 (2007). doi: 10.1093\/jnci\/djk179","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"1273_CR34","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.soc.2011.07.003","volume":"20","author":"MA Steliga","year":"2011","unstructured":"M.A. Steliga, C.M. Dresler, Epidemiology of lung cancer: smoking, secondhand smoke, and genetics. Surg. Oncol. Clin. N. Am. 20(4), 605\u2013618 (2011). doi: 10.1016\/j.soc.2011.07.003","journal-title":"Surg. Oncol. Clin. N. Am."},{"issue":"2","key":"1273_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/diagnostics5020119","volume":"5","author":"EE Ilett","year":"2015","unstructured":"E.E. Ilett, S.W. Langer, I.H. Olsen, B. Federspiel, A. Kjaer, U. Knigge, Neuroendocrine carcinomas of the gastroenteropancreatic system: a comprehensive review. Diagnostics (Basel) 5(2), 119\u2013176 (2015). doi: 10.3390\/diagnostics5020119","journal-title":"Diagnostics (Basel)"},{"key":"1273_CR36","unstructured":"European parliament and council of the European communities. Decision no. 1295\/1999\/EC of the European parliament and of the council of 29 April 1999 adopting a programme of community action on rare diseases within the framework for action in the field of public health (1999\u20132003). (1999)"},{"key":"1273_CR37","unstructured":"National Institutes of Health, Annual report on the rare diseases research activities at the National Institutes of Health, FY in 2005 (National Institutes of Health, Bethesda, MD, 2006)"},{"key":"1273_CR38","unstructured":"National Cancer Institute Epidemiology and Genetics Research, Synergizing epidemiologic research on rare cancers. Workshop, May 10-11 2007, Bethesda, MD."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-017-1273-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1273-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1273-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T16:32:24Z","timestamp":1568910744000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-017-1273-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,16]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["1273"],"URL":"https:\/\/doi.org\/10.1007\/s12020-017-1273-x","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,16]]}}}